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ABSTRACT
A segmented endograft includes at least one positioning
segment and at least one main body segment which are
separately deployable. The at least one positioning segment
and at least one main body segment may be connected one
to another. For example, the at least one positioning segment
and at least one main body segment may be connected along
a portion of a circumference thereof, but unconnected along
a remainder of the circumference thereof. The at least one
positioning segment overlaps a portion of the at least one
main body segment. Deployment systems may include the
segmented endograft and the segmented endograft may be
deployed according to various methods.
10 Claims, 4 Drawing Sheets
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GRAFT WITHIN A GRAFT ENDOLUMINAL
GRAFT

significant patient risk. Another strategy considered is partially constraining the endograft longitudinally during
deployment. However, a single piece endograft that is partially constrained longitudinally is still significantly
detached from its deployment catheter, limiting the repositioning force that can be applied to the graft by manipulation
of its deployment catheter at the remote introduction site.
There has accordingly been identified a need in the art for
an endoluminal graft which, while effective for its intended
purpose, provides additional advantages in allowing repositioning during placement in a diseased blood vessel, to
ensure the best positioning of the device to isolate the
vascular pathology being treated.

This application claims the benefit of priority in U.S.
Provisional Patent Application Ser. No. 61/487,050, filed on
May 17, 2011, the entirety of which is incorporated herein
by reference.
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TECHNICAL FIELD
10

The present disclosure relates generally to endoluminal
grafts. More particularly, the disclosure relates to endoluminal grafts including at least one separately deployable
portion facilitating remote positioning and repositioning of
the device within the lumen of a blood vessel.

15

BACKGROUND OF THE INVENTION
It is known to provide endoluminal grafts or endografts
for treating vascular lesions or pathologies such as aneurysms, stenosis, dissections, and others using minimally
invasive surgical techniques. A conventional endograft is
typically radially compressed or constrained, mounted on a
deployment catheter, introduced into the vasculature, and
advanced to its intended deployment site. Such conventional
endografts, as is known in the art, typically include a metal
lattice element (stent) which provides an expansile force and
a fabric (graft) designed to contain pressurized bloodflow
within its lumen, thereby excluding bloodflow from the site
of the vascular pathology or lesion. As is known, the stent
and graft portion of the endograft are typically attached one
to the other or incorporated one with the other, leading to the
common nomenclature "stent graft." Suitable materials for
fabricating such endografts are well known in the art.
Typically, endografts are introduced into the vasculature
from a location remote from the intended treatment zone, for
example a femoral artery. The endograft must then be
positioned and deployed so with the graft proximal and
distal ends bracketing the vascular lesion, further whereby
each graft end is positioned in a healthy portion of the blood
vessel being treated, to provide an occlusive seal. This
allows exclusion of the systemic blood pressure from the
diseased blood vessel segment. Inaccurate placement of an
endograft can result in ischemic complications from unintended coverage of branch vessels, or incomplete exclusion
of the pathology being treated because of minimal apposition of the endograft and the vessel wall in the sealing zone.
Further complicating the issue, the intervening healthy
"landing zone" between the vascular pathology and potentially important branch blood vessels is often very short.
In cases such as minimal "landing zones" for proper
placement of an endograft, the ability to re-position the
device prior to final placement can improve accuracy and
greatly improve the odds of safe and effective exclusion of
the diseased vascular segments. However, during deployment, endografts are subjected to the displacement forces of
the pressurized bloodflow in the vessel being treated, creating a "windsock" effect. Such displacement forces continue until the endograft is fully deployed or opened and
blood flow is established through the endograft lumen. For
conventional single piece endografts, however, at that point
the endograft has been disconnected from the positioning
device (such as a deployment catheter) and cannot be
repositioned.
Strategies have been proposed for overcoming this prob!em. These include temporarily arresting bloodflow (for
example by arresting the heart). However, this poses a
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SUMMARY OF THE INVENTION
In accordance with the foregoing need identified in the art
as described herein, an endoluminal graft or endograft is
provided. The disclosed endograft includes at least one
separately deployable portion for remote positioning and
repositioning of the device within the lumen of a blood
vessel. Advantageously, this feature facilitates the positioning, repositioning, and deployment of the device at a site of
a lesion or pathology in a body lumen, for example vascular
aneurysms, stenosis, dissections, and the like.
In one aspect, the disclosure relates to a segmented
endograft including at least one positioning segment and at
least one main body segment, each being separately deployable. The at least one positioning segment and the at least
one main body segment are partially connected one to the
other, typically along a portion of a circumference thereof,
but are separate one from the other along a remainder of the
circumference. An overlap is defined between adjoining
portions of the at least one positioning segment and the at
least one main body segment.
In the following description there are shown and
described several different embodiments of this invention,
simply by way of illustration of some of the modes best
suited to carry out the invention. As it will be realized, the
invention is capable of other different embodiments and its
several details are capable of modification in various, obvious aspects all without departing from the invention.
Accordingly, the drawings and descriptions will be regarded
as illustrative in nature and not as restrictive.
BRIEF DESCRIPTION OF THE DRAWINGS
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The accompanying drawings incorporated herein and
forming a part of the specification, illustrate several aspects
of the present invention and together with the description
serve to explain certain principles of the invention. In the
drawings:
FIGS. la and lb show a fully constrained segmented
endograft according to the present disclosure in perspective
and side cross-sectional view;
FIGS. 2a and 2b show the endograft of FIG. 1, with a
positioning segment deployed, with FIG. 2a showing the
deployed positioning segment in perspective view, and FIG.
2b showing the deployed positioning segment in a side
cross-sectional view;
FIGS. 3a and 3b show the endograft of FIG. 1 fully
deployed, with FIG. 3a showing a perspective view and FIG.
3b showing a side cross-sectional view; and
FIGS. 4a through 4c depict placement and deployment of
the endograft of FIG. 1 to isolate a lesion such as a vascular
aneurysm.
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Reference will now be made in detail to the present
preferred embodiments of the invention, examples of which
are illustrated in the accompanying drawings.

assembled deployment catheter/endograft 10 may be
advanced to the site of the lesion or pathology by sliding the
assembly over the guidewire. Alternatively, the endograft 10
may be delivered and deployed by a balloon dilation catheter
as is known in the art, Of course, it is contemplated to
monitor each step of delivery and deployment, such as by
known means including without limitation radiography,
x-ray fluoroscopy, intravascular ultrasound, and the like, to
confirm proper placement.
On reaching the site of a body lumen lesion or pathology
such as an aneurysm 26 in a wall of a blood vessel 28 (see
FIGS. 4a-4c), the endograft 10 is advanced until at least the
positioning segment 12 is positioned distally to the lesion or
pathology relative to the site at which the guidewire and
deployment catheter were introduced. Then, the positioning
segment 12 and overlap 16 are deployed (see FIGS. 2a, 2b,
and 4b). Any suitable methods of deployment are contemplated to deploy/expand positioning segment 12. For
example, use of one or more balloons of a balloon dilation
catheter of known design is contemplated, and also use of
self-expanding stent scaffold configurations (zig-zag stents,
etc.) or shape memory alloys. Again, proper initial placement of the positioning segment 12 of endograft 10 may be
monitored by any suitable means including visually, such as
by radiography and the like.
The skilled artisan will appreciate that positioning segment 12, once deployed against the wall 28 of the body
lumen, will assist in keeping the endograft 10 in place but
since less surface area of the endograft 10 is in contact with
an interior surface of the body lumen, will also facilitate any
repositioning of the endograft 10 which may be required for
optimal placement. In turn, the deployed positioning segment 12 also will allow blood flow through the lumen 22
thereof, thereby minimizing displacement of the device by
pressurized blood flow and further facilitating repositioning
of the endograft 10 as needed (with concurrent monitoring)
to ensure optimal placement of the endograft 10 over the
lesion or pathology. Because positioning segment 12 is
connected to main body segment 14 via attachment 24, the
two segments remain coupled allowing more efficient
manipulation from the remote introduction site via the
deployment catheter or dilation catheter, and also application of greater force in repositioning the device with less
concomitant concern about damage to the body lumen
interior such as would be expected from a fully deployed
conventional endograft.
Further, the endograft 10 may be remotely positioned and
repositioned as needed for optimal placement according to
the positioning, size, etc. of the lesion or pathology, the
proximity of the lesion or pathology to vascular branching,
etc. using the deployment catheter or balloon dilation catheter, which remains encased in the constrained main body
segment 14. In contrast, a conventional endograft, once
deployed, can no longer be manipulated using an associated
deployment catheter or the like, in that the lumen of the
endograft is enlarged and no longer in contact with the
catheter. As such, any manipulation of a conventional
endograft for repositioning same can only be done by
manipulating the endograft itself, which is inherently less
efficient.
On verification of proper placement, main body 14 is
deployed (see FIGS. 3a and 3b) by any suitable method as
was described for positioning segment 12, i.e. balloons,
self-expanding stent material, shape memory alloy stent
material, etc. For example, the balloon used to deploy
positioning segment 12 may be repositioned to deploy main
body segment 14, or a second balloon may be used. As best

DETAILED DESCRIPTION OF THE
INVENTION
In accordance with the foregoing need identified in the art
as described herein, an endoluminal graft or endograft is
provided. The disclosed endograft includes at least one
separately deployable portion for remote positioning and
repositioning of the device within the lumen of a blood
vessel. Advantageously, this feature facilitates the positioning, repositioning, and deployment of the device at a site of
a lesion or pathology in a body lumen, for example vascular
aneurysms, stenosis, dissections, and the like.
In one aspect, a segmented endograft 10 is provided. As
shown in FIGS. la and lb, the endograft 10 includes at least
one positioning segment 12 and at least one main body 14,
with positioning segment 12 defining an overlap 16 at
adjoining portions of the two segments. The endograft 10
may be fabricated of overlapping or integrated stent materials 18 and graft materials 20 (see FIG. lb), as is well
known in the art, wherein the stent material 18 comprises a
metal (or other suitable material) lattice structure which
provides the expansile force when the endograft is deployed.
In turn, the graft material 20 contains pressurized blood flow
within a lumen 22 thereof, thereby isolating that blood flow
from a diseased body lumen section.
In an embodiment (see especially FIG. lb), positioning
segment 12 and main body segment 14 may include integrated stent materials 18 and graft materials 20, but overlap
16 may be fabricated to include only graft materials 20. Any
suitable material or combination of materials for use as stent
and graft material, respectively, are contemplated. Lumen 22
also receives a deployment catheter (not shown) of known
configuration for delivering the endograft 10 to a site of a
body lumen lesion or pathology. In turn, as is also known in
the art, the deployment catheter will likewise define a central
lumen for receiving a guidewire of known design and
material, for use in guiding the deployment catheter and
associated endograft 10 to the site of the body lumen lesion
or pathology. Of course, other methods of delivery of an
endograft 10 are known, for example a dilation catheter (not
shown) of known design.
The positioning segment 12 and the main body segment
14 of the endograft 10 are partially connected at adjoining
portions thereof, such as at attachment 24 (best seen in
FIGS. 2 and 3). As best seen in FIGS. 2a and 2b, this may
be accomplished by attaching a portion of an exterior
circumference of a distal end of main body segment 14 to an
interior lumen 22 of positioning segment 12. In that fashion,
positioning segment 12 and main body segment 14 are
connected one to the other along a portion of a circumference thereof, but remain unconnected along the remainder of
their circumferences.
In use, the endograft 10 may be delivered to a site of a
body lumen lesion or pathology (see FIGS. 4a-4c) by
methods well known in the art. For example, the constrained
endograft 10 may receive a deployment catheter or balloon
dilation catheter in lumen 22 thereof. As discussed above,
the deployment catheter or balloon dilation catheter will
typically include a central lumen for receiving a guidewire
therein. The guidewire may be introduced into the body
from a remote site, for example a femoral artery, and
advanced to the site of the lesion or pathology via one or
more body lumens, for example via vasculature. Next, the
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shown in FIGS. 3a and 3b, on deployment an exterior
surface of main body 14 contacts an interior surface of
overlap 16, thereby forming a tight seal to prevent leakage
of fluid passing through lumen 22. In tum, exterior surfaces
of positioning segment 12, overlap 16, and main body 14
then contact interior surfaces of the wall 28 of the body
lumen being repaired, enlarged, etc.
The deployed endograft 10 may optionally then be further
enlarged, such as by a larger balloon, to provide additional
contact with the body lumen wall 28 interior and to anchor
proximal and distal ends of the endograft 10 above and
below the body lumen lesion or pathology, in contact with
healthy body lumen tissue, to provide the desired occlusive
seal and to isolate the lesion or pathology from blood flow.
Similar techniques may be employed as are known in the art
when the desired effect is also to enlarge a body lumen such
as that of a blood vessel, for example to relieve stenoses. Of
course, other methods for anchoring the deployed endograft
10 to the wall 28 of the body lumen are known and
contemplated for use herein, such as providing barbs (not
shown) protruding from the stent material 18 which engage
the wall 28.
It will be appreciated that the present endograft 10 provides significant advantages compared to conventional onepiece endoluminal grafts. The multi-segmented configuration, with separately deployable portions, facilitates remote
positioning and repositioning of the device, ensuring the
most accurate placement for isolation or exclusion of diseased body lumen tissue. Deployment of only a portion of
the endograft 10 during such repositioning minimizes displacement of the device by pressurized bloodflow and also
maintains physical coupling of the undeployed portion of the
endograft to, e.g., a guidewire to allow manipulation of the
endograft at areas of body lumen angulation. In tum, the
need to resort to conventional strategies for eliminating or
reducing displacement of the device by bloodflow during
such repositioning, such as temporarily arresting blood flow,
longitudinal constraint of the endograft during deployment,
etc., is obviated.
The foregoing description of preferred embodiments has
been presented for purposes of illustration and description.
It is not intended to be exhaustive or limiting to the invention
to the precise forms disclosed. Obvious modifications or
variations are possible in light of the above teachings. For
example, the depicted embodiments show a substantially
tubular or cylindrical endograft 10, but it is also known in
the art to provide such devices in a bifurcated or branched
configuration, as a tapered structure, etc. in tum, additional
deployable endograft 10 segments may be provided if necessary or desirable according to the size and positioning
(relative to other body lumens) of the body lumen lesion or
pathology.
The embodiments were chosen and described to provide
the best illustration of the principles described herein and
their practical application to thereby enable one of ordinary
skill in the art to utilize the invention in various embodiments and with various modifications as are suited to the
particular use contemplated. All such modifications and
variations are within the scope of the invention as determined by the appended claims when interpreted in accordance with the breadth to which they are fairly, legally and
equitably entitled.
What is claimed is:
1. A segmented endograft, comprising:
at least one positioning segment defined by a positioning
segment wall and including a first cylindrical section;
and

at least one main body segment having a main body
segment wall and including a second cylindrical section;
wherein the first cylindrical section of the at least one
positioning segment and the second cylindrical section
of the at least one main body segment overlap one
another along an entire length of both of the first
cylindrical section and the second cylindrical section
along a longitudinal axis of the segmented endograft
and are fixedly attached to one another at only a portion
of each of a circumference of the first cylindrical
section and a circumference of the second cylindrical
section, but are not attached to one another at a remainder of each of the circumference of the first cylindrical
section and the circumference of the second cylindrical
section;
wherein the at least one positioning segment is independently deployable with respect to the at least one main
body segment; and
further wherein on deployment of both the at least one
positioning segment and the at least one main body
segment, the at least one positioning segment and the at
least one main body segment define a fluid-impervious
lumen passing through the at least one positioning
segment and the at least one main body segment.
2. The segmented endograft of claim 1, wherein the at
least one positioning segment and the at least one main body
segment each comprise at least one stent material and at least
one graft material, and the overlap comprises only at least
one graft material.
3. The segmented endograft of claim 1, wherein the main
body segment wall is disposed at least partially within the
positioning segment wall.
4. The segmented endograft of claim 1, wherein on
independent deployment of the at least one positioning
segment, the at least one positioning segment and the at least
one main body segment do not define the fluid-impervious
lumen until independent deployment of the at least one main
body segment.
5. An endograft delivery system, comprising:
a segmented endograft comprising at least one positioning
segment defined by a positioning segment wall, said
positioning segment wall including a first cylindrical
portion, and at least one main body segment defined by
a main body segment wall, said main body segment
wall including a second cylindrical portion;
a deployment catheter configured to carry the endograft
and to be endoluminally advanced through a body
lumen from a remote introduction site to a site of a
body lumen lesion or pathology; and
a guidewire for guiding the deployment catheter;
wherein the first cylindrical portion of the at least one
positioning segment and the second cylindrical portion
of the at least one main body segment overlap one
another along an entire longitudinal length of each of
the first and second cylindrical portions and are fixedly
attached to one another at only a portion of the first
cylindrical portion and the second cylindrical portion,
but are not attached to one another at a remainder of
each of the first cylindrical portion and the second
cylindrical portion;
wherein the at least one positioning segment is independently deployable with respect to the at least one main
body segment; and
further wherein only upon deployment of both the at least
one positioning segment and the at least one main body
segment, the at least one positioning segment and the at
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least one main body segment define a tight seal therebetween, and wherein upon deployment of only the at
least one positioning segment and not the at least one
main body segment, said tight seal is not present.
6. The endograft delivery system of claim 5, wherein the
at least one positioning segment and the at least one main
body segment each comprise at least one stent material and
at least one graft material, and the overlap comprises only at
least one graft material.
7. The endograft delivery system of claim 5, wherein the
main body segment wall is disposed at least partially within
the positioning segment wall.
8. A method for deploying a segmented endograft, comprising:
providing a segmented endograft, the segmented
endograft comprising:
at least one positioning segment defined by a positioning segment wall and including a first cylindrical
section; and
at least one main body segment having a main body
segment wall and including a second cylindrical
section;
wherein the first cylindrical section of the at least one
positioning segment and the second cylindrical section of the at least one main body segment overlap
one another along an entire length of both of the first
cylindrical section and the second cylindrical section
along a longitudinal axis of the segmented endograft
and are fixedly attached to one another at only a
portion of each of a circumference of the first cylindrical section and a circumference of the second
cylindrical section, but are not attached to one
another at a remainder of each of the circumference
of the first cylindrical section and the circumference
of the second cylindrical section;
wherein the at least one positioning segment is independently deployable with respect to the at least one
main body segment; and

further wherein on deployment of both the at least one
positioning segment and the at least one main body
segment, the at least one positioning segment and the
at least one main body segment define a fluidimpervious lumen passing through the at least one
positioning segment and the at least one main body
segment;
delivering the segmented endograft in an undeployed state
from a remote introduction site to a site of a body
lumen lesion or pathology;
deploying the at least one positioning segment of the
segmented endograft independent of the at least one
main body segment at a site distal to the body lumen
lesion or pathology relative to the introduction site;
repositioning the segmented endograft as needed whereby
a distal and a proximal end of the segmented endograft
contact healthy body lumen tissue above and below the
body lumen lesion or pathology; and
deploying the at least one main body segment of the
segmented endograft whereby the at least one positioning segment and the at least one main body segment
define the fluid-impervious lumen passing through the
at least one positioning segment and the at least one
main body segment, to provide an occlusive seal of the
body lumen whereby the body lumen lesion or pathology is isolated from a flow of blood.
9. The method of claim 8, wherein the steps of delivering
the segmented endograft to the site of the body lumen lesion
or patholo?~' d~ploying the at least one positioning segment,
and repos1t10mng the segmented endograft are monitored
visually to confirm a proper deployment of the segmented
endograft.
10. The method of claim 9, wherein the at least one
positioning segment and the at least one main body segment
each comprise at least one stent material and at least one
graft material, and the overlap comprises only at least one
graft material.
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